1795 — Lotus Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Lotus Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	1,277	1,489	1,605	1,983	1,771
Net Total Accounts Receivable
Net Total Receivables	2,417	2,801	3,407	4,927	6,617
Total Inventory
Total Other Current Assets
Total Current Assets	5,721	6,783	8,333	10,661	12,653
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,049	2,305	2,642	3,148	3,511
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	18,195	19,753	21,222	29,526	32,992
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,101	4,883	4,326	5,893	4,524
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	10,453	11,008	10,153	15,658	15,658
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	7,742	8,745	11,069	13,868	17,334
Total Liabilities & Shareholders' Equity	18,195	19,753	21,222	29,526	32,992
Total Common Shares Outstanding